Large opportunity, New Approach needed
Gila is focused on development of products to provide comprehensive weight management solutions and treat metabolic diseases in specific target populations.
Gila Therapeutics is developing multiple natural peptides for the treatment of obesity, type 2 diabetes, NAFLD, NASH, CKD and cardiovascular disease.
- Addition of Pediatric, Adolescent treatment targets
1. Avoidance of weight gain
- Treatment of Type 2 Diabetes / Metabolic Disorders
2. weight loss
- Rx only effective when actively dosed.
- Many treatments cite 1-year data, but patient use is transient, offering transient benefit